Results 271 to 280 of about 2,034,935 (392)
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley +1 more source
Relapsing Chronic Immune Thrombocytopenia and Thrombosis: A Case Report. [PDF]
Kose L.
europepmc +1 more source
Long‐term remission of type B insulin resistance syndrome with immunotherapy: A case report
ABSTRACT We report long‐term remission in a patient with type B insulin resistance achieved with a combination of immunotherapies. A 55‐year‐old Japanese man presented with nocturnal hypoglycemia and cytopenia. He also had postprandial hyperglycemia due to severe insulin resistance, which was difficult to manage using high‐dose insulin and recombinant ...
Erika Egawa +3 more
wiley +1 more source
Combination of anti-CD20 and hetrombopag in relapsed/refractory immune thrombocytopenia: a case series. [PDF]
Zhang X +6 more
europepmc +1 more source
Malaria polymerase chain reaction (PCR) testing is more sensitive than conventional diagnostics. Routine PCR screening of at‐risk asymptomatic hematopoietic cell donors and transplant candidates may prevent unnecessary deferrals or treatment. In our experience, PCR negativity during screening or after treatment supports donor/candidate eligibility ...
Mary M. Czech +5 more
wiley +1 more source
Mesenchymal stem cells therapy for immune thrombocytopenia in pregnancy: a case report. [PDF]
Tong T +7 more
europepmc +1 more source
Immune Thrombocytopenia in Finnish Children and Adolescents: A Population‐Based Cohort Study [PDF]
Lauri‐Matti Kulmala +7 more
openalex +1 more source
Abstract Background Annually millions of platelet concentrate (PC) are transfused worldwide. The decision regarding PC transfusion is often complex; therefore, the implementation of a hospital programme designed to streamline and facilitate the decision‐making process is beneficial. Such a programme helps standardise transfusion practices, ensures that
Piotr F. Czempik +2 more
wiley +1 more source

